In a unanimous decision, the U.S. Supreme Court on Thursday rejected a case that sought to restrict access to the abortion drug mifepristone The court said the plaintiffs had no legal standing to bring the case forward The decision allows women to obtain the pill by mail, and to get it from health professionals other than doctors THURSDAY, June 13, 2024 (HealthDay News) -- The U.
S. Supreme Court on Thursday threw out a case that aimed to curb access to the controversial abortion drug mifepristone , saying the plaintiffs who brought the case to the court had no legal standing to do so. In a unanimous vote, the nine judges ruled that a group of doctors and other medical professionals -- represented by the conservative Christian legal group Alliance Defending Freedom -- had no legal right to challenge access to the abortion pill and dismissed the case.
“Today’s decision from the U.S. Supreme Court provides us with long-awaited relief.
We now know that patients and clinicians across the country will continue to have access to mifepristone for medication abortion and miscarriage management," Dr. Stella Dantas , president of the American College of Obstetricians and Gynecologists, said in a statement released after the ruling was issued. "Decades of clinical research have proven mifepristone to be safe and effective, and its strong track record of millions of patient uses confirms that data," she added.
At issue in the case were recent U.S. Food and Drug Administration regulato.
